-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shi Si Yao: Once Again Receives Order to Supply 1.2 Million Abidol Capsules to Hubei Province—A “National Mission”
Category:
Time：2020-02-26
On February 23, the Medical Supplies Guarantee Group of the Joint Prevention and Control Mechanism of the State Council for the Prevention and Control of the Novel Coronavirus Pneumonia Epidemic issued its second emergency task dispatch order to Shijiazhuang Sihua Pharmaceutical Co., Ltd., requiring the company to deliver in batches by March 8 a total of 1.2 million capsules of abidol hydrochloride—100,000 boxes—to Hubei Province.
On February 23, the Medical Supplies Guarantee Group of the Joint Prevention and Control Mechanism of the State Council for the Prevention and Control of the Novel Coronavirus Pneumonia Epidemic issued a second emergency task dispatch order to Shijiazhuang Sihua Pharmaceutical Co., Ltd., requiring the company to deliver in batches, by March 8, a total of 1.2 million capsules—100,000 boxes—of abidor hydrochloride capsules to Hubei Province.
After learning about the “national mission,” Qu Jiguang, Chairman of the Board of Directors of Shisi Pharmaceutical Group, once again stated that the company will deliver the relevant pharmaceutical products on time and in full compliance with the requirements outlined in the mission order.
At 6 p.m. on February 19, Shijiazhuang No. 4 Pharmaceutical Company received, for the first time, an “Emergency Task Dispatch Order” from the Medical Supplies Guarantee Group of the Joint Prevention and Control Mechanism of the State Council for the Novel Coronavirus Pneumonia Epidemic, requesting the company to overcome all difficulties and deliver, in batches, 50,000 boxes containing 600,000 capsules of abidol hydrochloride to Hubei Province by February 26.
▲On February 19, Shijiazhuang No.4 Pharmaceutical Company stepped up shipments of abidol hydrochloride capsules to Hubei Province.
The sales, finance, warehouse, and transportation departments coordinated closely and responded swiftly, promptly completing the outbound procedures. The large truck tasked with delivering 600,000 capsules of Abidol hydrochloride departed from Shijiazhuang at 4 p.m. on February 20 and traveled through the night and into the early hours of the next day. Early on February 21, it arrived at the warehouse of Sinopharm Holding Hubei Company in Wuhan. From receiving the mission order to delivering the emergency medication, Shijiazhuang Sihua Pharmaceutical took less than 39 hours.
“Supporting Hubei is a responsibility that our pharmaceutical company must fulfill. We must address Hubei’s urgent needs and the nation’s urgent priorities, and deliver this batch of medicines to Hubei at the earliest possible moment,” said Qu Jiguang. “Currently, we’ve already prepared the inventory for the second batch of shipments. As soon as the products pass inspection and are deemed qualified, we’ll immediately begin shipping them.”
Abidol Hydrochloride capsules are the flagship antiviral product of Shijiazhuang Fourth Pharmaceutical. Since the outbreak of the pandemic, a total of 2.48 million Abidol Hydrochloride capsules have been sent to Hubei Province, including 2.09 million capsules to Wuhan.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license